
Showing 1180 – 1190 of 1304 results
-
Verve Therapeutics Inc Initiation
William Blair initiated research coverage of Verve Therapeutics, Inc. (VERV $46.25). Verve Therapeutics is a technology-agnostic company focused on developing innovative, precision medicines for the treatment of cardiovascular diseases.
-
LifeStance Health Group, Inc. Initiation
William Blair initiated research coverage of LifeStance Health Group, Inc. (LFST $27.63), the largest provider of outpatient mental health services in the United States.
-
Sprinklr, Inc Initiation
William Blair initiated research coverage of Sprinklr, Inc. (CXM $19.51). Sprinklr is a leading unified customer experience management (CXM) platform that enables large enterprises to engage with customers on modern channels like social media, messaging, live chat, and text, operating across more than 30 such channels.
-
Anaplan Inc Initiation
William Blair & Company initiated research coverage of Anaplan, Inc. (PLAN $71.20), a cloud-based provider of connected planning software.
-
BTRS Holdings Inc Initiation
William Blair & Company initiated research coverage of BTRS Holdings, Inc. (BTRS $17.00). BTRS Holdings (Billtrust) is a leading provider of cloud-based software and integrated payment processing solutions that simplify and automate B2B commerce.
-
Lonza Group AG Initiation
William Blair & Company initiated research coverage of Lonza Group AG (LONN-SWX CHF 587.80). Lonza is the largest global contract development and manufacturing organization (CDMO), with particularly strong market share positions in biologics drug substance, small molecule high potency active pharmaceutical ingredients, antibody drug conjugates, and cell therapy.
-
Larimar Therapeutics Inc Initiation
William Blair & Company initiated research coverage of Larimar Therapeutics, Inc. (LRMR $15.44), a clinical-stage company developing proprietary intracellular-targeted therapeutics for orphan diseases, with an initial focus on Friedreich’s ataxia (FA), for which there are no FDA-approved therapies.
-
HireRight Holdings Corp Initiation
William Blair initiated research coverage of HireRight Holdings Corp. (HRT $17.35), a leading global provider of technology-enabled background screening products.
-
TELUS International (Cda) Inc. Initiation
William Blair & Company initiated research coverage of TELUS International (Cda) Inc. (TIXT $29.00). Telus International is a leading digital customer experience (CX) service provider with adjacent services focused on content moderation, data annotation, and artificial intelligence.
-
Lucira Health Inc Initiation
William Blair & Company initiated research coverage of Lucira Health, Inc. (LHDX $19.31). Lucira has developed on-the-spot molecular testing for infectious diseases with a single-use system, powered by two AA batteries, that fits in the palm of a hand.